Search Grant Opportunities

Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)

ID: RFA-AG-24-023 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

The central goal of this funding initiative is to evaluate the molecular, pathologic and functional consequences of major toxicants known to be associated with elevated AD/ADRD risk, in mouse models of Late Onset AD (LOAD). Projects funded through this program will examine the consequences of early and mid-life exposure on late-life brain health by conducting cross-sectional/longitudinal multi-modal phenotyping (molecular, biochemical, pathologic and behavioral) of mouse models of LOAD, and the impact of genetic diversity and sex-differences on exposure-related AD outcomes.
Background
The central goal of this funding initiative is to evaluate the molecular, pathologic and functional consequences of major toxicants known to be associated with elevated AD/ADRD risk, in mouse models of Late Onset AD (LOAD). Projects funded through this program will examine the consequences of early and mid-life exposure on late-life brain health by conducting cross-sectional/longitudinal multi-modal phenotyping (molecular, biochemical, pathologic and behavioral) of mouse models of LOAD. The impact of genetic diversity and sex-differences on exposure-related AD outcomes will also be studied.

Grant Details
It is well appreciated that the complexity and heterogeneity of AD/ADRD is a consequence of a dynamic interaction between genes and environment over the lifespan. Although a growing body of epidemiologic, genomic, and mechanistic research points to a significant contribution of various environmental factors (i.e., the exposome) on AD/ADRD risk and resilience, our understanding of the impact of the exposome on the etiology of AD/ADRD is still rudimentary. This funding initiative aims to establish a research consortium that will utilize mouse models of AD, including polygenic mouse models, for comprehensive assessment of the impact of AD/ADRD-relevant environmental toxicants on multiple aspects of brain aging and AD/ADRD related outcomes. The data, analytical resources, and mechanistic insights delivered by this initiative may inform new strategies for AD/ADRD risk assessment, risk reduction, and disease prevention.

Eligibility Requirements
Eligible applicants include higher education institutions, nonprofits with 501(c)(3) IRS status, for-profit organizations, state governments, county governments, city or township governments, special district governments, Indian/Native American Tribal Governments (Federally Recognized), U.S. Territory or Possession agencies, independent school districts, public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), faith-based or community-based organizations, regional organizations, non-domestic (non-U.S.) entities (Foreign Institutions), foreign components of U.S. Organizations are also eligible to apply.

Period of Performance
The period of performance for this grant opportunity starts from October 23, 2023. The maximum project period is 5 years.

Grant Value
NIA intends to commit $4 million in fiscal year 2024 to support 2 awards. Application budgets are capped at $1.25 million in direct costs per year.

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 5/15/23 the National Institutes of Health posted grant opportunity RFA-AG-24-023 for Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed). The grant will be issued under grant program 93.866 Aging Research.

Timing

Posted Date
May 15, 2023, 12:00 a.m. EDT
Closing Date
Oct. 23, 2023, 12:00 a.m. EDT Past Due
Last Updated
May 16, 2023, 12:53 p.m. EDT
Version
1
Archive Date
Nov. 28, 2023

Eligibility

Eligible Applicants
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
State governments
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Public and State controlled institutions of higher education
Special district governments
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$1,250,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-023.html

Documents

Posted documents for RFA-AG-24-023

Grant Awards

Grants awarded through RFA-AG-24-023

Incumbent or Similar Grants

Grants similar to RFA-AG-24-023

Similar Active Opportunities

Open grant opportunities similar to RFA-AG-24-023